| Gene therapy in a patient with sickle cell disease JA Ribeil, S Hacein-Bey-Abina, E Payen, A Magnani, M Semeraro, ... New England Journal of Medicine 376 (9), 848-855, 2017 | 757 | 2017 |
| Gene therapy in patients with transfusion-dependent β-thalassemia AA Thompson, MC Walters, J Kwiatkowski, JEJ Rasko, JA Ribeil, ... New England Journal of Medicine 378 (16), 1479-1493, 2018 | 698 | 2018 |
| Recurrent attacks of acute hepatic porphyria: major role of the chronic inflammatory response in the liver C Schmitt, H Lenglet, A Yu, C Delaby, A Benecke, T Lefebvre, P Letteron, ... Journal of internal medicine 284 (1), 78-91, 2018 | 111 | 2018 |
| Heterozygous mutations in BMP6 pro-peptide lead to inappropriate hepcidin synthesis and moderate iron overload in humans R Daher, C Kannengiesser, D Houamel, T Lefebvre, E Bardou-Jacquet, ... Gastroenterology 150 (3), 672-683. e4, 2016 | 97 | 2016 |
| A variant erythroferrone disrupts iron homeostasis in SF3B1-mutated myelodysplastic syndrome S Bondu, AS Alary, C Lefèvre, A Houy, G Jung, T Lefebvre, D Rombaut, ... Science Translational Medicine 11 (500), eaav5467, 2019 | 74 | 2019 |
| Acute intermittent porphyria causes hepatic mitochondrial energetic failure in a mouse model C Homedan, J Laafi, C Schmitt, N Gueguen, T Lefebvre, Z Karim, ... The international journal of biochemistry & cell biology 51, 93-101, 2014 | 68 | 2014 |
| Metabolomics for personalized medicine: the input of analytical chemistry from biomarker discovery to point-of-care tests FA Castelli, G Rosati, C Moguet, C Fuentes, J Marrugo-Ramírez, ... Analytical and bioanalytical chemistry 414 (2), 759-789, 2022 | 67 | 2022 |
| Hepcidin as a major component of renal antibacterial defenses against uropathogenic Escherichia coli D Houamel, N Ducrot, T Lefebvre, R Daher, B Moulouel, MA Sari, ... Journal of the American Society of Nephrology 27 (3), 835-846, 2016 | 66 | 2016 |
| Cardiac iron overload in chronically transfused patients with thalassemia, sickle cell anemia, or myelodysplastic syndrome M de Montalembert, JA Ribeil, V Brousse, A Guerci-Bresler, ... PLoS One 12 (3), e0172147, 2017 | 65 | 2017 |
| LC-MS/MS method for hepcidin-25 measurement in human and mouse serum: clinical and research implications in iron disorders T Lefebvre, N Dessendier, D Houamel, N Ialy-Radio, C Kannengiesser, ... Clinical Chemistry and Laboratory Medicine (CCLM) 53 (10), 1557-1567, 2015 | 61 | 2015 |
| Provisional standardization of hepcidin assays: creating a traceability chain with a primary reference material, candidate reference method and a commutable secondary reference … LE Diepeveen, CMM Laarakkers, G Martos, ME Pawlak, FF Uğuz, ... Clinical Chemistry and Laboratory Medicine (CCLM) 57 (6), 864-872, 2019 | 52 | 2019 |
| Iron status and inflammatory biomarkers in patients with acutely decompensated heart failure: early in-hospital phase and 30-day follow-up. LNL Van Aelst, M Abraham, M Sadoune, T Lefebvre, P Manivet, D Logeart, ... European journal of heart failure 19 (8), 1075-1076, 2017 | 52 | 2017 |
| Molecular and functional analysis of the C-terminal region of human erythroid-specific 5-aminolevulinic synthase associated with X-linked dominant protoporphyria (XLDPP) S Ducamp, X Schneider-Yin, F de Rooij, J Clayton, EJ Fratz, A Rudd, ... Human molecular genetics 22 (7), 1280-1288, 2013 | 52 | 2013 |
| Iron deficiency diagnosed using hepcidin on critical care discharge is an independent risk factor for death and poor quality of life at one year: an observational prospective … S Lasocki, T Lefebvre, C Mayeur, H Puy, A Mebazaa, E Gayat Critical care 22, 1-8, 2018 | 51 | 2018 |
| Impact of treating iron deficiency, diagnosed according to hepcidin quantification, on outcomes after a prolonged ICU stay compared to standard care: a multicenter, randomized … S Lasocki, P Asfar, S Jaber, M Ferrandiere, T Kerforne, K Asehnoune, ... Critical Care 25, 1-10, 2021 | 30 | 2021 |
| Regulation and tissue-specific expression of δ-aminolevulinic acid synthases in non-syndromic sideroblastic anemias and porphyrias K Peoc'h, G Nicolas, C Schmitt, A Mirmiran, R Daher, T Lefebvre, L Gouya, ... Molecular Genetics and Metabolism 128 (3), 190-197, 2019 | 28 | 2019 |
| Clinical measurement of Hepcidin-25 in human serum: Is quantitative mass spectrometry up to the job? C Delaby, J Vialaret, P Bros, A Gabelle, T Lefebvre, H Puy, C Hirtz, ... EuPA Open Proteomics 3, 60-67, 2014 | 26 | 2014 |
| Urinary Metabolic Fingerprint of Acute Intermittent Porphyria Analyzed by 1H NMR Spectroscopy M Carichon, N Pallet, C Schmitt, T Lefebvre, L Gouya, N Talbi, ... Analytical chemistry 86 (4), 2166-2174, 2014 | 26 | 2014 |
| Predominant role of microglia in brain iron retention in Sanfilippo syndrome, a pediatric neurodegenerative disease V Puy, W Darwiche, S Trudel, C Gomila, C Lony, L Puy, T Lefebvre, S Vitry, ... Glia 66 (8), 1709-1723, 2018 | 25 | 2018 |
| Erythroid-progenitor-targeted gene therapy using bifunctional TFR1 ligand-peptides in human erythropoietic protoporphyria A Mirmiran, C Schmitt, T Lefebvre, H Manceau, R Daher, V Oustric, A Poli, ... The American Journal of Human Genetics 104 (2), 341-347, 2019 | 23 | 2019 |
